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ABSTRACT 20 
Polymeric films were prepared based on chitosan and its blends with poly(2-ethyl-2-oxazoline) 21 
by casting from aqueous solutions. These materials were characterised using a number of 22 
physicochemical techniques, including Fourier-transform infrared spectroscopy, thermal gravimetric 23 
analysis, differential scanning calorimetry, wide angle x-ray diffraction, tensile testing and scanning 24 
electron microscopy. All these studies indicate that there is a weak intermacromolecular hydrogen 25 
bonding between these polymers, which facilitates their complete miscibility in solid state. These 26 
films were formulated with sodium fluorescein as a model drug and were evaluated for their potential 27 
application in ocular drug delivery both in vitro and in vivo. It was established that the films are 28 
biocompatible and mucoadhesive; they are capable of providing a sustained drug release when 29 
administered topically on the cornea. 30 
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1. INTRODUCTION 32 
Ability of hydrophilic polymers to stick to wet surfaces in the human body, defined as 33 
mucoadhesion, has been widely used for designing dosage forms for transmucosal administration. 34 
The current applications of mucoadhesive dosage forms include drug delivery to the eye, nose, oral 35 
cavity, gastrointestinal tract, vagina, rectum and urinary bladder [1–5]. These routes of drug 36 
administration offer a number of advantages and the use of mucoadhesive carriers facilitates better 37 
dosage form retention on mucosal surfaces resulting in improved drug bioavailability, possibility of 38 
targeting particular organs, ease of application and avoidance of painful injections. 39 
Typically, all water-soluble polymers have some mucoadhesive properties; however, either 40 
positively or negatively charged polyelectrolytes exhibit better ability to stick to mucosal tissues 41 
compared to non-ionic macromolecules [2]. Chitosan as a polysaccharide of cationic nature is 42 
considered as one of the materials with excellent mucoadhesive properties and its numerous 43 
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applications in transmucosal drug delivery have been demonstrated [6–8]. Many attempts have been 44 
reported to modify mucoadhesive properties of chitosan through its chemical modification, as 45 
discussed in a recent review by Ways et al [9]. Additionally, properties of chitosan could also be 46 
altered by simple blending with other polymers. For example, Luo et al [10] demonstrated that 47 
chitosan forms miscible blends with hydroxyethylcellulose, which resulted in reduction of 48 
mucoadhesive properties of the buccal films based on the mixtures of these polymers. Freag et al [11] 49 
reported the development of mucoadhesive sponges based on blends of chitosan with 50 
hydroxypropylmethylcellulose and demonstrated that the materials prepared from 1:1 polymer 51 
mixture exhibited the best physicochemical characteristics suitable for buccal administration. Sizílio 52 
et al [12] fabricated mucoadhesive films by blending chitosan with poly(N-vinyl pyrrolidone) and 53 
evaluated their application for delivery of betamethasone-17-valerate used in the therapy of recurrent 54 
aphthous stomatitis. 55 
Poly(2-oxazolines) is an emerging class of polymers highly promising for biomedical 56 
applications due to their non-toxicity, bio-inert nature and unique physicochemical properties [13–57 
17]. Water-soluble representatives of this class such as poly(2-methyl-2-oxazoline), poly(2-ethyl-2-58 
oxazoline), and poly(N-propyl-2-oxazoline) have received a lot of attention of researchers due to their 59 
unique physicochemical properties such as the ability to form hydrogen-bonded complexes with 60 
polycarboxylic acids and tannins [18–20] as well as their temperature-responsive properties [21]. Due 61 
to their bio-inert nature, low molecular weight poly(2-methyl-2-oxazoline) and poly(2-ethyl-2-62 
oxazoline) (5 kDa) were reported to facilitate mucus-penetration of silica nanoparticles through 63 
porcine stomach mucosa [22,23] and to reduce their mucoadhesion to rat intestinal tissues [24]. 64 
Poly(2-ethyl-2-oxazolines) with larger molecular weights (50, 200 and 500 kDa) exhibited weak 65 
mucoadhesive properties and their simple blends and complexes with Carbopols 971 and 974 also 66 
resulted in reduction of dosage forms mucoadhesiveness compared to pure Carbopols® [25]. 67 
Polymer blending and miscibility of poly(2-oxazolines) with other polymers is studied 68 
insufficiently. Earlier publications reported the miscibility studies of poly(2-oxazolines) with 69 
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hydroxyl-containing polymers [26–28] and some conventional plastic materials such as poly(vinyl 70 
chloride), polystyrene, polypropylene and poly(vinylidene fluoride) [29]. Despite the growing 71 
biomedical importance of both chitosan and poly(2-oxazolines) the studies of miscibility in their 72 
blends are limited only to a very few publications [30]. 73 
In the present work we have prepared chitosan/poly(2-ethyl-2-oxazoline) films by casting from 74 
aqueous mixtures of these polymers; studied the physicochemical properties of these blends using 75 
Fourier transform infrared spectroscopy, thermal analysis and X-ray diffraction methods, tensile 76 
properties, and scanning electron microscopy; and evaluated the mucoadhesive potential and 77 
retention of these films on freshly excised bovine cornea ex vivo and on rabbit ocular cornea in vivo. 78 
2. EXPERIMENTAL SECTION 79 
2.1. Materials 80 
A high molecular weight chitosan (CHI, MW ~ 310 – 375 kDa, degree of deacetylation: 75 – 81 
85%), poly(2-ethyl-2-oxazoline) (POZ, MW ~ 50 kDa and PDI 3 – 4), hydrochloric acid solution 82 
(HCl, 1 M), fluorescein sodium salt (NaFl) and phosphate buffered saline (PBS) tablets were 83 
purchased from Sigma-Aldrich (Gillingham, UK). All other chemicals were of analytical grade and 84 
used without further purification. 85 
2.2. Preparation of films 86 
Chitosan solution was prepared by first dissolving 3.75 g of chitosan in 25 mL of 1 M HCl, 87 
then the total volume was made up to 500 mL with deionised water (CHI 0.75% w/v, pH ~ 4.0) and 88 
stirred magnetically overnight at room temperature. Before casting CHI solution was sonicated in a 89 
sonication bath (FS200b, Decon Laboratories Ltd., UK) for 30 min. Poly(2-ethyl-2-oxazoline) 90 
solutions (0.75% w/v) were prepared by dissolving 3.75 g polymer powder in 500 mL of deionised 91 
water (pH ~ 6.8) for 1 h under continuous stirring. The film-forming solutions (FFS) with and without 92 
NaFl (0.1 mg/mL) were obtained by mixing CHI and POZ aqueous solutions at different volume 93 
ratios, where part of CHI was gradually replaced with POZ, up to 60%. Formulations were named 94 
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indicating the CHI/POZ volume ratio as CHI (100), (80:20), (60:40), (40:60) and POZ (100), 95 
respectively. The pH values of combined solutions were in the range of 4.0 – 4.2. FFS were 96 
magnetically stirred for 3 h until fully homogeneous mixture formed, after that, 45 mL of each 97 
solution was poured into 90 mm diameter Petri dishes and dried at room temperature for several days. 98 
2.3. Fourier transform infrared (FTIR) spectroscopy 99 
FTIR spectra were recorded on Nicolet iS5 FTIR spectrometer (Thermo Scientific, UK) using 100 
an attenuated total reflectance (ATR) accessory equipped with a diamond crystal. The transmission 101 
mode was used and the resolution was 1 cm-1. 102 
2.4. Thermogravimetric analysis (TGA) 103 
Thermogravimetric analysis of CHI, POZ and CHI/POZ blend film samples was conducted 104 
using Q50 TGA analyser (TA Instruments, UK) in the range between 20 and 600 °C at a heating rate 105 
of 10 °C/min under nitrogen atmosphere. Moisture content in each film was determined from the 106 
weight loss corresponding to the first step weight loss in their TGA curves (up to about 150 °C). 107 
2.5. Differential scanning calorimetry (DSC) 108 
Differential scanning calorimetry (DSC) measurements were performed on TA-Q2000 DSC 109 
instrument (TA Instruments, UK). DSC thermograms of each film were recorded from the second 110 
heating run at 20 °C/min, after the first run of heating up to 80 °C and cooling down to 25 °C at 10 111 
°C/min, under nitrogen atmosphere, in order to estimate the glass transition temperatures (Tg). 112 
2.6. X-Ray diffraction (XRD) 113 
X-Ray diffraction patterns of the polymers and their blends were evaluated using Oxford 114 
Diffraction Gemini Ultra diffractometer fitted with CuKα radiation and Saturn detector (Oxford 115 
Diffraction Ltd., UK). Film samples were cut in 11 cm, loaded, and scanned at diffraction ranges 116 
from 6 to 120° with a scan step of 0.01°, generating characteristic diffractograms at the rate of 2.5 117 
scans min-1. 118 
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2.7. Scanning electron microscope (SEM) 119 
SEM experiments used a FEI Quanta 600 FEG Environmental Scanning Electron Microscope 120 
instrument (FEI UK Ltd., UK) with an acceleration voltage of 20 kV. The images were taken from 121 
the fracture surface of the materials, which were preliminary frozen in liquid nitrogen and coated with 122 
gold sputter to facilitate high resolution imaging. 123 
2.8. Mechanical analysis 124 
Puncture strength (PS) and elongation at break (EB) of the films were measured using a TA.XT 125 
Plus Texture Analyser (Stable Micro Systems Ltd., UK) in compression mode at room temperature 126 
[31,32]. Film thickness was measured with a hand-held micrometer; six replicates were taken for each 127 
sample in different places and the mean values were calculated accordingly. The thickness of the 128 
films was about 0.065 ± 0.002 mm. The square shaped film samples (30 x 30 mm) fixed by screws 129 
between two plates with a cylindrical hole of 10 mm diameter (area of the sample holder hole: Ars = 130 
78.54 mm2) and compressed by the upper load 5 mm stainless steel spherical ball probe (P/5S) at a 131 
test speed 1.0 mm/sec. The plate was stabilised to avoid movements using two pins. The 132 
measurements started after the probe was in contact with the sample surface. The probe moved at a 133 
constant speed until each film sample was broken [33]. These tests were performed with the following 134 
settings: pre-speed test 2.0 mm/sес; test-speed 1.0 mm/sес; post-test speed 10.0 mm/sес; target mode 135 
– distance; distance 5 mm; trigger type auto; trigger force 0.049 N. The film samples were punctured 136 
and the force required in Newtons was recorded and puncture strength was calculated using the 137 
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where Force is the maximum applied force recorded during strain. 140 
Elongation at break (EB) is the ratio between the extension of the film at the point of rupture 141 







− 1) × 100%      (2) 143 
where 𝑎′ – the initial length of the film sample that is not punctured by the probe; b – the penetration 144 
depth/vertical displacement by the probe; r – the radius of the probe; and a – radius of the film in the 145 
sample holder opening. 146 
All experiments were conducted 5 times and the mean values ± standard deviations were 147 
calculated and evaluated statistically. 148 
2.9. Ex vivo mucoadhesion studies on bovine cornea 149 
The retention of polymeric films on bovine eyes was studied using the protocols previously 150 
reported by our group with some modifications [35,36]. The bovine eyes are commonly used in ocular 151 
drug delivery and irritation testing because of their availability, suitable dimensions and structural 152 
similarity to human eyes [37]. These were acquired from P.C. Turner Abattoirs (Farnborough, UK) 153 
immediately after animal slaughter and were transported to the laboratory in a cold polystyrene 154 
container. Bovine corneas were dissected within 4 h of eyes delivery, where the whole cornea with 155 
2-3 mm of sclera was carefully excised using a sharp blade. Each cornea was rinsed with PBS 156 
solution, placed in Petri dishes, wrapped with cling film to reduce dehydration and stored at 4 °C to 157 
be used on the following day. Each experiment was performed in triplicate using different corneas. 158 
Experiments were carried out with a cornea mounted on a glass slide placed on half cut falcon 159 
tubes already mounted at an angle of 45° and maintained at 37 °C in an incubator. Prior to each 160 
experiment, spherically shaped polymeric discs (4 mm in diameter) containing NaFl were quickly 161 
soaked in 0.9% NaCl saline solution (1 sec) and then placed on cornea previously rinsed with 1 mL 162 
of simulated tear fluid (STF: 3.35 g NaCl; 1 g NaHCO3; and 0.0305 g CaCl2 made up to 500 mL with 163 
deionised water). The background microscopy images were recorded for each cornea prior to 164 
administration of a fluorescent film. Then 12 mL of STF solution was dripped for 1 h on a corneal 165 
surface at a flow rate of 200 µL/min using a syringe pump. Fluorescence microscopy images of whole 166 
tissue were recorded after each wash every 5 min using a Leica MZ10F stereo-microscope (Leica 167 
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Microsystems, UK) with Leica DFC3000G digital camera at 0.8× magnification and 20 ms exposure 168 
time (gain 3.0×), fitted with a GFP filter (blue, λemission = 512 nm). The microscopy images were then 169 
analysed with ImageJ software by measuring the fluorescence pixel intensity after each washing 170 
cycle. The pixel intensity of the blank samples (corneal mucosa without a fluorescent film) was 171 
deducted from each measurement and data were normalised and converted into fluorescent intensity 172 
values using the following equation: 173 
𝐹𝑙𝑢𝑜𝑟𝑒𝑠𝑐𝑒𝑛𝑐𝑒 𝑖𝑛𝑡𝑒𝑛𝑠𝑖𝑡𝑦 =  
𝐼− 𝐼𝑏
𝐼0− 𝐼𝑏
 × 100%     (4) 174 
where 𝐼 is the fluorescence intensity of a given tissue sample with a mucoadhesive film after each 175 
washing; 𝐼𝑏 is the background fluorescence intensity of that tissue sample (a blank sample); and 𝐼0 is 176 
the initial fluorescence intensity of that sample (a tissue sample with mucoadhesive film on it prior 177 
to the start of first washing). 178 
In parallel, STF solution flowing through the corneal epithelium was collected at pre-179 
determined time points and used for determination of the percentage of NaFl washed off the corneal 180 
surface. All the collected samples were diluted with STF, making up the total volume to 30 mL. The 181 
amount of NaFl in each sample was then quantified using a FP-6200 spectrofluorometer (Jasco, UK) 182 
at λexcitation and λemission wavelengths of 460 and 512 nm, respectively. A standard curve used to 183 
determine the amount of NaFl released from the films can be found in Supplementary information 184 
(Figure S1). 185 
All measurements were conducted in triplicate and the mean values ± standard deviations were 186 
calculated and evaluated statistically. 187 
2.10. In vivo experiments 188 
In vivo experiments on ocular administration of fluorescent films (CHI and CHI/POZ) were 189 
conducted using chinchilla rabbits (2.5 – 4.0 kg) according to a previously described protocol [38]. 190 
These experiments were approved by Semey State Medical University (Kazakhstan) ethics committee 191 
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and were conducted following the ARVO Statement for the Use of Animals in Ophthalmic and Visual 192 
Research. Before the start of experiments, rabbits were housed in standard cages and allowed free 193 
access to food and water. In the beginning of each experiment rabbits were sedated with 0.2 mL (100 194 
mg/mL) sodium thiopental (Arterium Corporation, Ukraine), previously dissolved in 10 mL of 0.9% 195 
NaCl saline solution, administered through the lateral auricular vein. Approximately 5 min after 196 
administration of sodium thiopental, polymeric discs containing NaFl (10 mm in diameter) were 197 
quickly soaked (1 sec) in a saline solution (0.9% NaCl) and carefully placed on rabbit left eye’s 198 
cornea; their right eye always served as a control. The behaviour of each polymeric disc on the eye 199 
was controlled visually and images were taken at different time intervals with a high resolution digital 200 
camera. In addition, a weak UV light from an UVGL-25 Compact UV handheld lamp (Ultra-Violet 201 
Products, UK) was shone into the eye to facilitate the detection of fluorescence. 202 
Each type of polymeric film was tested in 3 rabbits and each experiment was conducted until a 203 
film was detached or dislodged. The mean residence time values ± standard deviations were 204 
calculated and assessed for statistical differences. 205 
2.11. Statistical analysis 206 
Data acquired during these experiments, i.e. mean values ± standard deviations were calculated 207 
and assessed for significance using two-tailed Student’s t-test and a one-way analysis of variance 208 
(ANOVA) followed by Bonferoni post hoc test using GraphPad Prism statistical analysis software 209 
(version 7.0; GraphPad Software Inc.), where p < 0.05 was considered as statistically significant. 210 
3. RESULTS AND DISCUSSION 211 
3.1. Preparation and characterisation of films 212 
CHI and CHI/POZ blend films were successfully developed and tested. These two polymers 213 
are well characterised for their safety and biocompatibility and known to be stable under normal 214 
processing and storage conditions. POZ solutions (0.75% w/v) used to prepare films were easy to 215 
handle and no heating was required during their dissolution in deionised water. Chitosan solution can 216 
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be obtained only via solvent casting from acidified water. All films were prepared without any 217 
plasticisers and were homogenous and transparent. 218 
The presence of amide carbonyl groups in poly(2-ethyl-2-oxazoline) suggests that this tertiary 219 
polyamide has potential for forming miscible blends with a variety of polymers containing 220 
complementary functional groups such as carboxylic, phenolic or alcoholic hydroxyl groups [39–41]. 221 
Previous studies demonstrated that carbonyl groups of POZ exhibit proton-accepting properties and 222 
participate in hydrogen bonding with proton-donating groups of other functional polymers [40,42]. 223 
Chitosan, in contrast to poly(2-ethyl-2-oxazoline), has in its structure numerous hydroxyl groups that 224 
can act as proton-donors with respect to the proton-accepting groups of POZ and form intermolecular 225 
hydrogen bonds. In order to establish the possibility of hydrogen bonding in chitosan/POZ blends all 226 
films were studied using FTIR spectroscopy (Figure 1). The FTIR spectrum of pure CHI film shows 227 
the presence of the broad peak appeared above 3000 cm-1 that is due to OH- stretching, which overlaps 228 
with NH-stretching in the same region. The peaks at 2923 cm-1 and 2889 cm-1 correspond to CH2- 229 
and CH- stretching vibrations. The absorption bands at 1627 cm-1 and 1520 cm-1 are C=O stretching 230 
(amide I) and NH-bending (amide II), respectively. The absorption band at 1416 cm-1 is attributed to 231 
CH- and OH- vibrations [10]. The band that appeared at 1377 cm-1 is assigned to the acetamide 232 
groups, which demonstrate that chitosan is not totally deacetylated and the peak at 1316 cm-1 can be 233 
due to C–N stretching (amide III) [43]. According to Bonilla et al [44] the peak at 1250 cm-1 234 
corresponds to amino groups. The peak occurred at 1151 cm-1 is the anti-symmetric stretching of the 235 
C–O–C bridge, 1062 cm-1 and 1024 cm-1 are the skeletal vibrations involving the C–O stretching, 236 
which are characteristics of chitosan polysaccharide structure [45]. 237 
The FTIR spectrum of POZ shows the presence of the broad absorption peak at 3488 cm-1, 238 
which is an indication of the presence of bound water that was not eliminated from the film 239 
completely. The absorption bands at 2977 cm-1 and 2939 cm-1 correspond to CH2-stretching 240 
vibrations. The characteristic bands at 1624 cm-1 and 1419 cm-1 are assigned to C=O stretching (amide 241 
I) and CH3 bending, respectively [22]. The absorption bands at 1470, 1374 and 1322 cm
-1 (CH 242 
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bending) as well as 1237, 1194 and 1061 cm-1 (C-C stretching) are in good agreement with FTIR data 243 
on POZ reported in the literature [46]. 244 
All the characteristic bands of the component polymers are present in the spectra of their blends 245 
and the intensities of the bands and the shape of the peaks depend on the polymers ratio in the blend. 246 
The spectra of the miscible CHI/POZ blends show significant changes in hydroxyl stretching region, 247 
suggesting a redistribution in the arrangement of the hydroxyl group associations. When comparing 248 
the spectra corresponding to the same system as a function of composition, a shift of this band toward 249 
higher wavenumbers is observed for increasing content of POZ. This behaviour suggests that a 250 
significant part of the hydroxyl groups involved in CHI are hydrogen-bonded to amide carbonyl 251 
groups in POZ. This is in good agreement with the data reported by Fang et al [30]. 252 
 253 
Figure 1. FTIR spectra of chitosan, POZ and CHI/POZ blends. 254 
Thermogravimetric analysis indicates that degradation of pure chitosan film proceeds via two 255 
main stages (Figure 2): first, it starts to loose physically-bound water at >30 C and this process 256 
finishes at 135 C. The amount of this physically bound water in pure CHI film is about 13 %. The 257 
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next thermal decomposition stage appears at 178 – 300 °C (with a maximum degradation rate 258 
observed at 188 °C); this degradation results in 52% loss of chitosan weight. This is caused by 259 
depolymerisation of chitosan chains and pyranose rings through dehydration and deamination and 260 
finally ring-opening reaction [47,48]. The pure POZ film shows greater thermal stability compared 261 
to 100 % CHI: the first thermal event begins above 30 °C, which is related to the evaporation of 262 
physically-bound water (approximately 8%). The second stage of thermal decomposition of POZ 263 
starts above 315 °C (with the maximal degradation rate observed at 395 °C) reaching 92% of the total 264 
weight loss at 430 °C. A single decomposition stage of dry POZ at 400 C was previously reported 265 
by Beruhil Adatoz et al [49], which broadly agrees with our data. The decomposition profiles of 266 
CHI/POZ blends are characterised by three stages: (1) 25 – 150 C, corresponding to the loss of 267 
physically bound water, (2) 175 – 275 C, corresponding to the degradation of CHI, and (3) 275 – 268 
425 C, corresponding to the degradation of POZ. It should be noted that the temperatures, at which 269 
the degradation rates of stages (2) and (3) were maximal, showed a good correlation with the 270 
composition of the blends (Figure S2, Supplementary information). This indicates that the presence 271 
of more thermally stable POZ in the blend improves the thermal stability of less stable chitosan, which 272 
may be due to the presence of weak hydrogen bonding between these polymers. 273 
 274 
Figure 2. TGA curves of pure CHI, pure POZ and CHI/POZ blend films. 275 
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Differential scanning calorimetry (DSC) was used to characterize the miscibility between the 276 
polymers. Usually the presence of a single glass transition temperature, situated between Tg values 277 
of individual polymer components indicates a complete miscibility. Figure 3 shows that the presence 278 
of a single glass transition in the blends, which depends on the composition of the polymer mixture. 279 
All glass transition temperatures of the blends are between the Tg values of individual POZ (56 C) 280 
and chitosan (131 C), which is in good agreement with the data reported by Fang et al [30]. 281 
 282 
Figure 3. DSC thermograms of pure CHI, pure POZ and CHI/POZ blend films. 283 
X-ray diffraction (WAXD) method was used to probe the effect of blending on crystallinity of 284 
polymers (Figure 4). WAXD diffractograms of pure CHI and POZ films show a broad halo typical 285 
for predominantly amorphous polymers. Pure CHI still shows the presence of four diffraction peaks 286 
at 2θ = 8.5°; 11.8°; 18.1° and 23.8°, which is typical for crystalline domains in this polysaccharide 287 
and is consistent with our previous report [50]. The diffractogram of pure POZ film shows the 288 
presence of two broad amorphous humps centred at 2θ = 10.4° and 18.8°, indicating non-crystalline 289 
nature of this polymer, which is also consistent with the literature data [51,52]. 290 
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Diffraction peaks characteristic of chitosan are also present in the blend film, however a shift 291 
of a broad diffraction peak from 23.3° to 19.2° is observed. This may indicate that chitosan is involved 292 
in some weak interaction with POZ that affects the formation and structure of its crystalline domains. 293 
 294 
Figure. 4. WAXD diffractograms of CHI and CHI/POZ blend films. 295 
The morphology of the polymer film cross-sections and surface were studied by scanning 296 
electron microscope (SEM). The investigation of the sample cross-sections at high magnification 297 
(2000×) reveals that the films have fully homogeneous structure with no signs of phase separation 298 
and interface boundaries (Figure 5). Thus, the SEM data provides another evidence for miscibility 299 
between CHI and POZ in the solid state at different ratios. 300 
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 301 
Figure 5. SEM images of (A) CHI, (B) pure POZ, and their blend (C, D, E) cross- sections and (F) 302 
surface. Content of POZ in the blends: 20 (C), 40 (D) and 60 % (E, F). Scale bars are 20 µm. 303 
The films composed of the blends with different CHI and POZ ratios were examined by 304 
elongation and puncture strength analysis and the results are shown in Figure 6. A film composed of 305 
pure POZ was not suitable for this type of analysis because of its extreme brittleness. Comparing the 306 
mechanical properties of pure CHI films with the polymer blends indicates that an increase in POZ 307 
content in the sample results in gradual reduction in the elongation at break and puncture strength 308 
values. 309 
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     310 
Figure 6. Mechanical analysis of CHI and CHI/POZ blend films: elongation at break (A) and 311 
puncture strength (B). Data are expressed as mean ± standard deviation (n = 5). Statistically 312 
significant differences are given as: *** – p < 0.001; * – p < 0.05; ns – no significance. 313 
3.2. Mucosal retention of blend films on ex vivo corneal tissue 314 
Soluble or swellable polymeric films have been used in ocular therapeutics either to improve 315 
the efficiency of drug delivery (compared to conventional eye drops), or to protect the injured cornea 316 
[53–55]. These films should exhibit some mucoadhesive properties to have a prolonged residence on 317 
the mucosa; however, eventually these materials are supposed to dissolve in the tear fluid completely 318 
or should allow their non-traumatising detachment from the ocular surface. These dosage forms 319 
should have excellent mechanical properties and a balanced mucoadhesiveness. Materials with 320 
insufficiently mucoadhesive properties will not be suitable because of the difficulties in their 321 
attachment to the ocular surface and, on the contrary, excessively films will cause discomfort because 322 
they may interfere with blinking [56]. Chitosan has previously been reported as a potential material 323 
for preparation of mucoadhesive ocular films [57–60]. It exhibits superior mucoadhesive properties 324 
compared to many other pharmaceutical polymers, which often needs to be moderated to make it 325 
suitable for a particular application. In the present work we have evaluated the suitability of CHI/POZ 326 
blends as materials for application as mucoadhesive ocular films. 327 
Fluorescein sodium (NaFl) was used as a model drug to demonstrate the potential use of 328 
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CHI/POZ films for the application in ocular drug delivery. The retention of CHI and CHI/POZ films 329 
containing 0.1% NaFl on freshly isolated bovine cornea was assessed using a flow-through in vitro 330 
technique with fluorescent detection. This methodology has been previously used to study the 331 
retention of various materials on different mucosal surfaces, including ocular tissues, and it was 332 
validated against the other techniques established in assessment of mucoadhesive properties 333 
[35,36,38,61,62]. Figure 7 illustrates exemplary fluorescent images of the retention of polymeric 334 
films on bovine corneal mucosa irrigated with STF (200 µL/min). The fluorescence intensity on the 335 
mucosa was monitored following each washing cycle over 60 min. After analysing the fluorescent 336 
images using ImageJ software, it can be seen that CHI and CHI/POZ films showed an initial increase 337 
in fluorescence intensity after the first wash (Figure 8). This can potentially be related to the moisture 338 
effect on fluorescent films, causing an increased brightness that leads to >100% fluorescence intensity 339 
values. Despite of this initial increase in the fluorescence intensity, the subsequent washes resulted in 340 
the reduction of fluorescence intensity due to the dissolution of the films and subsequent wash out of 341 
NaFl. It was established that 100% CHI and CHI/POZ (80:20 and 60:40) exhibited significantly 342 
greater retention (p < 0.01) in the initial washing cycles (except for CHI after 60 min washing, 12 343 
mL STF, p < 0.05) compared to CHI/POZ (40:60). It could be concluded that introduction of POZ 344 
made the films less retentive. This observation is consistent with our previous studies reporting that 345 
decorating nanoparticles with POZ makes them less mucoadhesive [22–24]. Moreover, the retention 346 
of CHI/POZ films (80:20 and 60:40) on ocular mucosa was found not to be significantly different 347 
from CHI (p > 0.05) demonstrating a similar retention profile until the end of washing cycles (Figure 348 
8). 349 
In parallel, STF solution flowing down the corneal surface during each washing cycle was 350 
collected at pre-determined time intervals and analysed using fluorescent spectrometry. An insert in 351 
Figure 8 depicts the cumulative percentage release of fluorescein sodium from CHI and CHI/POZ 352 
films. It was revealed that CHI/POZ (40:60) films released the highest amount of NaFl after total 353 
washing cycle over 60 min compared to 100% CHI and CHI/POZ (80:20 and 60:40). In the course 354 
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of work, the use of NaFl with the concentration higher than 0.1 mg/mL led to the formation of strong 355 
complexes with chitosan and precipitation of complexes were observed. Fluorescein sodium is a 356 
negatively charged compound and therefore may form complexes with the positively charged 357 
backbones of chitosan due to the electrostatic attraction forces. Hence, NaFl with lower concentration 358 
was used to prepare fluorescent films based on different ratios of CHI and POZ. Considering the 359 
composition of CHI/POZ fluorescent films, therefore, the lower content of chitosan in the blend film, 360 
the more NaFl is released. The fact that 100% CHI released less NaFl could be explained by partial 361 
entrapment of fluorescein sodium within the corneal epithelium, or/and by mucoadhesive effects of 362 
chitosan, i.e. specific interactions of chitosan macromolecules with the ocular surface. 363 
 364 
Figure 7. Exemplary fluorescent microphotographs showing mucosal retention of CHI and CHI/POZ 365 
films on freshly excised bovine cornea washed with different volumes of STF (200 µL/min) over 60 366 
min. Scale bars are 1 μm. 367 
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 368 
Figure 8. Mucosal retention of CHI and CHI/POZ films on fresh bovine cornea after irrigating with 369 
different volumes of STF (200 µL/min) over 60 min. All values are the means ± standard deviations 370 
of triplicate experiments. Statistically significant differences are given as: ** – p < 0.01; * – p < 0.05. 371 
3.3. In vivo retention studies 372 
Taking into consideration the known non-toxic and non-irritant nature of both chitosan and 373 
POZ [14,63] the mucoadhesive films were tested directly in vivo without prior evaluation of their 374 
biocompatibility in cell culture or other in vitro irritation models. 375 
In vivo experiments were carried out in rabbits (n = 3) with round-shaped 10 mm CHI and 376 
CHI/POZ films containing 0.1 mg/mL NaFl. Each formulation was placed on corneal mucosa of a 377 
chinchilla rabbit’s left eye and their retention was monitored visually by taking photographs at regular 378 
time points until the films detached. A UV lamp was used to enhance the detection of fluorescence. 379 
Figure 9 shows exemplary images of rabbit eyes with fluorescent films administered in vivo 380 
providing even coverage of the cornea and subsequent changes were observed, i.e. time of 381 
20 
detachment, physical changes such as films swelling and wrinkling. The results for all other 382 
formulations are presented in Figures S3-S6 (Supplementary information). Films made of 100% POZ 383 
were not suitable for in vivo experiments due to their extreme brittleness. The in vivo results indicate 384 
that pure CHI and CHI/POZ films could achieve from at least 10 min to up to 50 min residence on 385 
the ocular surface, which is consistent with in vitro data. Generally, all the films exhibited excellent 386 
adhesion to the cornea. However, the presence of a nictitating membrane on chinchilla rabbit cornea 387 
often led to the dislodging or a complete removal of the films from the corneal surface into the lower 388 
fornix of conjunctiva. This greatly affected in vivo data reproducibility. No significant differences (p 389 
> 0.05) were observed between all film formulations in terms of their retention on the rabbit’s cornea 390 
(Figure 10). It is expected that these films will exhibit much better retention in human tests because 391 
these dosage forms will not be voluntarily dislodged or removed. It should also be noted that the films 392 
did not cause any observable discomfort, irritation, inflammatory reactions or excessive tear 393 
production in rabbit eyes, which indicate that these materials are biocompatible and potentially 394 
suitable for ocular administration. 395 
 396 
Figure 9. Exemplary photographs of in vivo mucosal retention of CHI/POZ (80:20) films on rabbit 397 
eyes taken at different time intervals. 398 
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 399 
Figure 10. In vivo mucosal retention of CHI and CHI/POZ blend films on rabbit eye. Data are 400 
expressed as mean ± standard deviation (n = 3). 401 
4. CONCLUSIONS 402 
Polymeric blends of chitosan and poly(2-ethyl-2-oxazoline) were prepared in the form of 403 
flexible and transparent films using casting from aqueous solutions with subsequent solvent 404 
evaporation. The structure and physicochemical properties of these films were evaluated using 405 
Fourier-transformed infrared spectroscopy, thermal gravimetric analysis, differential scanning 406 
calorimetry, wide angle x-ray diffraction, tensile testing and scanning electron microscopy. These 407 
studies indicated a complete miscibility between the polymers in the blends. Blending of chitosan and 408 
poly(2-ethyl-2-oxazoline) leads to a significant reduction of the films mechanical properties 409 
(elongation at break and puncture strength). The films based on pure chitosan and blends with poly(2-410 
ethyl-2-oxazoline) were formulated with sodium fluorescein and evaluated as potential dosage forms 411 
for ocular drug delivery both in vitro and in vivo. The results indicate that these films are 412 
biocompatible and do not cause any irritation to the eye. They also exhibit ability to adhere to the 413 
cornea and to retain for up to 50 min, providing a sustained drug release. 414 
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